Pure Financial Advisors, LLC

Position in AQST — Aquestive Therapeutics, Inc.

CIK 1571556 SAN DIEGO, CA

Position in AQST

as of Mar 31, 2026 · filed Apr 10, 2026 Compact

Position Value

$91,092

New position

Shares Held

21,950

first reported quarter

Ownership

0.017%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Pure Financial Advisors, LLC holds $775,771 across 5 Drug Manufacturers - Specialty & Generic names. AQST ranks #3 (11.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	2,535	$333,960
2	TAK	Takeda Pharmaceutical Co Ltd	13,575	$251,409
3	AQST	Aquestive Therapeutics, Inc. This page	21,950	$91,092
4	EOLS	Evolus, Inc.	17,995	$73,959
5	CRON	Cronos Group Inc.	10,100	$25,351

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$91,092	21,950	—	Shares	Sole	2026-04-10
No filing history on record for this holder in this stock.